Tesamorelin — 5mg | Research Use Only (RUO)

Description

A synthetic analog of growth hormone releasing factor (GRF) with a trans-3-hexenoic acid modification, currently being investigated in controlled laboratory environments for its interaction with GHRH receptor signaling pathways.

For laboratory research use only. Not for human or animal consumption.

OVERVIEW

Tesamorelin is a modified synthetic peptide that has been studied in preclinical models for its interaction with GHRH receptors. Its structural modification at the N-terminus with trans-3-hexenoic acid has been examined for its effect on peptide stability and receptor binding duration compared to unmodified GHRH analogs. Laboratory research has focused on its signaling characteristics and pathway activation under controlled experimental conditions.

Supplied as a lyophilized powder for analytical and experimental research applications.

PRODUCT SPECIFICATIONS

Compound: Tesamorelin
Quantity: 5 mg per vial
Form: Lyophilized powder
Purity: ≥98%
Storage: -20°C recommended, protect from light
CAS: 218949-48-5

RESEARCH APPLICATIONS

– Modified GHRH analog receptor binding studies
– N-terminal modification and peptide stability research
– Growth hormone pathway signaling analysis
– Comparative GHRH analog potency studies

RESEARCH USE ONLY

This product is intended strictly for laboratory research purposes. Not for human consumption. Not for veterinary use. Not for therapeutic or diagnostic applications. Not intended to treat, cure, or prevent any condition. Use is limited to qualified professionals in controlled laboratory environments.

Certificate of Analysis available upon request.